Internal Server Error

List of Lilly's Acquisitions

lockFilter this list
Lilly has made a total of 38 acquisitions. These activities spanned 27 sectors, including Oncology, Neurology, and Immunotherapy, across 6 countries, most notably United States, Canada, and United Kingdom. Peak acquisition years were 2026 with 9, 2023 with 6, and 2025 with 3, while the average from 2020–2025 was 2.8 per year. To date, 9 acquisitions have been completed in the current calendar year. The most recent is 4E Therapeutics, an Austin-based developer of neuropathic pain drugs founded in 2019 and acquired in June 2026.

Here's the year on year acquisition history of Lilly:

Year on year acquisition history of Lilly2026202520242023202220212020201920182017Acquisitions Round Date (Yearly)0246810
  • Number of Total Acquisitions
Year
# Acquisitions
2026
9
2025
3
2024
2
2023
6
2022
2
2021
1
2020
3
2019
1
2018
2
2017
1
2016
1
2014
1
2011
1
2010
2
2008
2
2007
1

Recent acquisitions by Lilly

Lilly's most recent acquisition - 4E Therapeutics is a Developer of drugs for treating neuropathic pain, founded in 2019 and located in Austin. Lilly acquired it in June 2026 for a price of $*****.

Here is the list of all acquisitions by Lilly sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jun 16, 2026
stry
mjyy
63
153
May 26, 2026
fgnt
bepq
97
877
May 20, 2026
uurv
tzvu
60
375
Apr 27, 2026
kkjz
bcc{
98
524
Apr 20, 2026
qlln
lbmu
10
284

View the full list of acquisitions

Sign Up for Free

News related to Lilly's acquisitions

lockFilter this list

Media has covered Lilly for a total of 559 events in the last 1 year, 79 of them have been about acquisition activity.

View More Lilly Recent News

FAQs about Acquisitions by Lilly

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford